This inventor holds 2 USPTO granted patents. Top assignees: Dongkook Pharmaceutical Co., Ltd., Other. Active years: 1995-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chungcheongbuk-do, KR (1995)
- Cheongju, KR (1996)
Company Filing History:
2 out of 25 
2 out of 834,513 Years Active: 1995-1996
Title: The Innovative Contributions of Won T Cho
Introduction
Won T Cho is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of aclacinomycins, which are important compounds in cancer treatment. With a total of 2 patents to his name, his work has garnered attention in the scientific community.
Latest Patents
Cho's latest patents focus on a novel method for producing aclacinomycins A, B, and Y using a specific strain of Streptomyces. The first patent discloses a method for cultivating Streptomyces lavendofoliae DKRS (KCTC 0092BP) to achieve higher yields of aclacinomycins A, B, Y, and their aglycone. Furthermore, it highlights the ability to selectively produce aclacinomycin A or Y by adjusting the pH of the cultured broth. The second patent reiterates this innovative approach, emphasizing the potential for increased production efficiency in anti-tumor aclacinomycins.
Career Highlights
Throughout his career, Won T Cho has worked with Dongkook Pharmaceutical Co., Ltd., where he has contributed to advancements in pharmaceutical research and development. His expertise in microbiology and biochemistry has played a crucial role in his innovative work.
Collaborations
Cho has collaborated with notable colleagues, including Wan Soo Kim and Myung K Kim. These partnerships have further enhanced his research and development efforts in the field of biotechnology.
Conclusion
Won T Cho's contributions to the production of aclacinomycins represent a significant advancement in cancer treatment. His innovative methods and collaborations continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile